SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Alexandre Louvet, Philippe Mathurin, Alcoholic liver disease: mechanisms of injury and targeted treatment, Nature Reviews Gastroenterology & Hepatology, 2015, 12, 4, 231

    CrossRef

  2. 2
    Phillipp Hartmann, Caroline T. Seebauer, Bernd Schnabl, Alcoholic Liver Disease: The Gut Microbiome and Liver Cross Talk, Alcoholism: Clinical and Experimental Research, 2015, 39, 5
  3. 3
    Chandrayee Ghosh, Biswadev Bishayi, Characterization of Toll-Like Receptor-4 (TLR-4) in the Spleen and Thymus of Swiss Albino Mice and Its Modulation in Experimental Endotoxemia, Journal of Immunology Research, 2015, 2015, 1

    CrossRef

  4. 4
    Won Kim, Diagnostic and Therapeutic Strategies for Severe Alcoholic Hepatitis, The Korean Journal of Gastroenterology, 2015, 65, 1, 4

    CrossRef

  5. 5
    Peng Chen, Peter Stärkel, Jerrold R. Turner, Samuel B. Ho, Bernd Schnabl, Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice, Hepatology, 2015, 61, 3
  6. 6
    Huanzhou Li, Ping Qiu, Juanhong Wang, Congcong Niu, Suhua Pan, Effects of compound Ginkgo biloba on intestinal permeability in rats with alcohol-induced liver injury, Food Funct., 2015, 6, 2, 470

    CrossRef

  7. 7
    Fatemeh Momen-Heravi, Shashi Bala, Karen Kodys, Gyongyi Szabo, Exosomes derived from alcohol-treated hepatocytes horizontally transfer liver specific miRNA-122 and sensitize monocytes to LPS, Scientific Reports, 2015, 5, 9991

    CrossRef

  8. 8
    Gyongyi Szabo, Gut–Liver Axis in Alcoholic Liver Disease, Gastroenterology, 2015, 148, 1, 30

    CrossRef

  9. 9
    Igor Maricic, Huiming Sheng, Idania Marrero, Ekihiro Seki, Tatiana Kisseleva, Som Chaturvedi, Natasha Molle, Stephanie A. Mathews, Bin Gao, Vipin Kumar, Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice, Hepatology, 2015, 61, 4
  10. 10
    Cristina Llorente, Bernd Schnabl, The Gut Microbiota and Liver Disease, CMGH Cellular and Molecular Gastroenterology and Hepatology, 2015, 1, 3, 275

    CrossRef

  11. 11
    Chang Seok Bang, So Hyung Hong, Ki Tae Suk, Jin Bong Kim, Sang Hak Han, Hotaik Sung, Eun Ji Kim, Myoung Jo Kim, Moon Young Kim, Soon Koo Baik, Dong Joon Kim, Effects of Korean Red Ginseng (Panax ginseng), urushiol (Rhus vernicifera Stokes), and probiotics (Lactobacillus rhamnosus R0011 and Lactobacillus acidophilus R0052) on the gut–liver axis of alcoholic liver disease, Journal of Ginseng Research, 2014, 38, 3, 167

    CrossRef

  12. 12
    Pranoti Mandrekar, Aditya Ambade, Immunity and inflammatory signaling in alcoholic liver disease, Hepatology International, 2014, 8, S2, 439

    CrossRef

  13. 13
    Phillip Levine, Kelly McDaniel, Heather Francis, Lindsey Kennedy, Gianfranco Alpini, Fanyin Meng, Molecular mechanisms of stem cell therapy in alcoholic liver disease, Digestive and Liver Disease, 2014, 46, 5, 391

    CrossRef

  14. 14
    Chia-Lin Chen, Hidekazu Tsukamoto, Keigo Machida, Oncogenic signaling pathways and origins of tumor-initiating stem-like cells of hepatocellular carcinomas induced by hepatitis C virus, alcohol and/or obesity, Hepatology International, 2014, 8, 3, 330

    CrossRef

  15. 15
    M. Galicia-Moreno, G. Gutiérrez-Reyes, Papel del estrés oxidativo en el desarrollo de la enfermedad hepática alcohólica, Revista de Gastroenterología de México, 2014, 79, 2, 135

    CrossRef

  16. 16
    Nobuhiro Nakamoto, Takanori Kanai, Role of Toll-Like Receptors in Immune Activation and Tolerance in the Liver, Frontiers in Immunology, 2014, 5,

    CrossRef

  17. 17
    Kelly McDaniel, Leonardo Herrera, Tianhao Zhou, Heather Francis, Yuyan Han, Phillip Levine, Emily Lin, Shannon Glaser, Gianfranco Alpini, Fanyin Meng, The functional role of microRNAs in alcoholic liver injury, Journal of Cellular and Molecular Medicine, 2014, 18, 2
  18. 18
    Tomoki Sato, Akihito Morita, Nobuko Mori, Shinji Miura, The role of glycerol-3-phosphate dehydrogenase 1 in the progression of fatty liver after acute ethanol administration in mice, Biochemical and Biophysical Research Communications, 2014, 444, 4, 525

    CrossRef

  19. 19
    M. Galicia-Moreno, G. Gutiérrez-Reyes, The role of oxidative stress in the development of alcoholic liver disease, Revista de Gastroenterología de México (English Edition), 2014, 79, 2, 135

    CrossRef

  20. 20
    Hui Liu, Jun Li, Brittany Tillman, Timothy R. Morgan, Barbara A. French, Samuel W. French, TLR3/4 signaling is mediated via the NFκB-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory–Denk bodies, Experimental and Molecular Pathology, 2014, 97, 2, 234

    CrossRef

  21. 21
    Vivek Kesar, Joseph A. Odin, Toll-like receptors and liver disease, Liver International, 2014, 34, 2
  22. 22
    Gyongyi Szabo, Dora Lippai, Neuroimmune Signaling in Drug Actions and Addictions, 2014,

    CrossRef

  23. 23
    Han-Qiang Liu, Ya Qiu, Ying Mu, Xian-Jiao Zhang, Lu Liu, Xiang-Hong Hou, Lei Zhang, Xiao-Na Xu, Ai-Ling Ji, Rui Cao, Rui-Hua Yang, Feng Wang, A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD rats, Nutrition Research, 2013, 33, 10, 849

    CrossRef

  24. 24
    Jin-Seok Byun, Yang-Gun Suh, Hyon-Seung Yi, Young-Sun Lee, Won-Il Jeong, Activation of toll-like receptor 3 attenuates alcoholic liver injury by stimulating Kupffer cells and stellate cells to produce interleukin-10 in mice, Journal of Hepatology, 2013, 58, 2, 342

    CrossRef

  25. 25
    Eric S Orman, Gemma Odena, Ramon Bataller, Alcoholic liver disease: Pathogenesis, management, and novel targets for therapy, Journal of Gastroenterology and Hepatology, 2013, 28,
  26. 26
    Ying Wan, Shuang Jiang, Li-Hua Lian, Ting Bai, Peng-He Cui, Xiao-Ting Sun, Xue-Jun Jin, Yan-Ling Wu, Ji-Xing Nan, Betulinic acid and betulin ameliorate acute ethanol-induced fatty liver via TLR4 and STAT3 in vivo and in vitro, International Immunopharmacology, 2013, 17, 2, 184

    CrossRef

  27. 27
    Phillipp Hartmann, Peng Chen, Hui J. Wang, Lirui Wang, Declan F. McCole, Katharina Brandl, Peter Stärkel, Clara Belzer, Claus Hellerbrand, Hidekazu Tsukamoto, Samuel B. Ho, Bernd Schnabl, Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice, Hepatology, 2013, 58, 1
  28. 28
    Jan Petrasek, Timea Csak, Michal Ganz, Gyongyi Szabo, Differences in innate immune signaling between alcoholic and non-alcoholic steatohepatitis, Journal of Gastroenterology and Hepatology, 2013, 28,
  29. 29
    Shunichiro Okazaki, Satoshi Nagoya, Kenji Tateda, Ryuichi Katada, Keisuke Mizuo, Satoshi Watanabe, Toshihiko Yamashita, Hiroshi Matsumoto, Experimental rat model for alcohol-induced osteonecrosis of the femoral head, International Journal of Experimental Pathology, 2013, 94, 5
  30. 30
    Alexander Wree, Lori Broderick, Ali Canbay, Hal M. Hoffman, Ariel E. Feldstein, From NAFLD to NASH to cirrhosis—new insights into disease mechanisms, Nature Reviews Gastroenterology & Hepatology, 2013, 10, 11, 627

    CrossRef

  31. 31
    Valérie Lebrun, Olivier Molendi-Coste, Nicolas Lanthier, Christine Sempoux, Patrice D. Cani, Nico van Rooijen, Peter Stärkel, Yves Horsmans, Isabelle A. Leclercq, Impact of PPAR-α induction on glucose homoeostasis in alcohol-fed mice, Clinical Science, 2013, 125, 11, 501

    CrossRef

  32. 32
    Yuhua Wang, Yanlong Liu, Irina Kirpich, Zhenhua Ma, Cuiling Wang, Min Zhang, Jill Suttles, Craig McClain, Wenke Feng, Lactobacillus rhamnosus GG reduces hepatic TNFα production and inflammation in chronic alcohol-induced liver injury, The Journal of Nutritional Biochemistry, 2013, 24, 9, 1609

    CrossRef

  33. 33
    Shuhong Guo, Rana Al-Sadi, Hamid M. Said, Thomas Y. Ma, Lipopolysaccharide Causes an Increase in Intestinal Tight Junction Permeability in Vitro and in Vivo by Inducing Enterocyte Membrane Expression and Localization of TLR-4 and CD14, The American Journal of Pathology, 2013, 182, 2, 375

    CrossRef

  34. 34
    A. L. Neves, J. Coelho, L. Couto, A. Leite-Moreira, R. Roncon-Albuquerque, Metabolic endotoxemia: a molecular link between obesity and cardiovascular risk, Journal of Molecular Endocrinology, 2013, 51, 2, R51

    CrossRef

  35. 35
    Hui-Hui Ye, Ke-Jian Wu, Su-Juan Fei, Xue-Wei Zhang, He-Xia Liu, Jiao-Li Zhang, Yong-Mei Zhang, Propofol participates in gastric mucosal protection through inhibiting the toll-like receptor-4/nuclear factor kappa-B signaling pathway, Clinics and Research in Hepatology and Gastroenterology, 2013, 37, 1, e3

    CrossRef

  36. 36
    Jung-Woo Kang, Dong-Wook Kim, Jae Sue Choi, Yeong Shik Kim, Sun-Mee Lee, Scoparone attenuates d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure through inhibition of toll-like receptor 4 signaling in mice, Food and Chemical Toxicology, 2013, 57, 132

    CrossRef

  37. 37
    Rafaz Hoque, Ahmad Farooq, Wajahat Z Mehal, Sterile inflammation in the liver and pancreas, Journal of Gastroenterology and Hepatology, 2013, 28,
  38. 38
    J. Petrasek, A. Iracheta-Vellve, T. Csak, A. Satishchandran, K. Kodys, E. A. Kurt-Jones, K. A. Fitzgerald, G. Szabo, STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease, Proceedings of the National Academy of Sciences, 2013, 110, 41, 16544

    CrossRef

  39. 39
    Pengfei Yu, Xiangdong Cheng, Yian Du, Ling Huang, Ruizeng Dong, TAK-242 can be the potential agents for preventing invasion and metastasis of hepatocellular carcinoma, Medical Hypotheses, 2013, 81, 4, 653

    CrossRef

  40. 40
    Hideto Kawaratani, Tatsuhiro Tsujimoto, Akitoshi Douhara, Hiroaki Takaya, Kei Moriya, Tadashi Namisaki, Ryuichi Noguchi, Hitoshi Yoshiji, Masao Fujimoto, Hiroshi Fukui, The Effect of Inflammatory Cytokines in Alcoholic Liver Disease, Mediators of Inflammation, 2013, 2013, 1

    CrossRef

  41. 41
    Veerle Bieghs, Christian Trautwein, The innate immune response during liver inflammation and metabolic disease, Trends in Immunology, 2013, 34, 9, 446

    CrossRef

  42. 42
    Yoon Seok Roh, Ekihiro Seki, Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis, Journal of Gastroenterology and Hepatology, 2013, 28,
  43. 43
    Keigo Machida, Tumor-initiating stem-like cells and drug resistance: carcinogenesis through Toll-like receptors, environmental factors, and virus, Drug Delivery and Translational Research, 2013, 3, 2, 152

    CrossRef

  44. 44
    Jan Petrasek, Timea Csak, Gyongyi Szabo, 2013,

    CrossRef

  45. 45
    Anita Zahs, Robert T. Cook, Thomas J. Waldschimdt, Mashkoor A. Choudhry, Elizabeth J. Kovacs, Melanie D. Bird, Alcohol and inflammation and infection: clinical and experimental systems—summary of the 2010 Alcohol and Immunology Research Interest Group Meeting, Alcohol, 2012, 46, 2, 147

    CrossRef

  46. 46
    Jonathan R Potts, Sumita Verma, Alcoholic hepatitis: diagnosis and management in 2012, Expert Review of Gastroenterology & Hepatology, 2012, 6, 6, 695

    CrossRef

  47. 47
    Areum Cha, Youngshim Choi, Yoojeong Jin, Mi-Kyung Sung, Yun-Chang Koo, Kwang-Won Lee, Taesun Park, Antilipogenic and Anti-Inflammatory Activities ofCodonopsis lanceolatain Mice Hepatic Tissues after Chronic Ethanol Feeding, Journal of Biomedicine and Biotechnology, 2012, 2012, 1

    CrossRef

  48. 48
    Angela Dolganiuc, Paul G. Thomes, Wen-Xing Ding, John J. Lemasters, Terrence M. Donohue, Autophagy in Alcohol-Induced Liver Diseases, Alcoholism: Clinical and Experimental Research, 2012, 36, 8
  49. 49
    Shashi Bala, Jan Petrasek, Shiv Mundkur, Donna Catalano, Ivan Levin, Jeanine Ward, Hawau Alao, Karen Kodys, Gyongyi Szabo, Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases, Hepatology, 2012, 56, 5
  50. 50
    Ren-Bo Ding, Ke Tian, Li-Li huang, Cheng-Wei He, Yun Jiang, Yi-Tao Wang, Jian-Bo Wan, Herbal medicines for the prevention of alcoholic liver disease: A review, Journal of Ethnopharmacology, 2012, 144, 3, 457

    CrossRef

  51. 51
    Jan Petrasek, Shashi Bala, Timea Csak, Dora Lippai, Karen Kodys, Victoria Menashy, Matthew Barrieau, So-Yun Min, Evelyn A. Kurt-Jones, Gyongyi Szabo, IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice, Journal of Clinical Investigation, 2012, 122, 10, 3476

    CrossRef

  52. 52
    H. Joe Wang, Bin Gao, Samir Zakhari, Laura E. Nagy, Inflammation in Alcoholic Liver Disease, Annual Review of Nutrition, 2012, 32, 1, 343

    CrossRef

  53. 53
    Shashi Bala, Gyongyi Szabo, MicroRNA Signature in Alcoholic Liver Disease, International Journal of Hepatology, 2012, 2012, 1

    CrossRef

  54. 54
    Aditya Ambade, Pranoti Mandrekar, Oxidative Stress and Inflammation: Essential Partners in Alcoholic Liver Disease, International Journal of Hepatology, 2012, 2012, 1

    CrossRef

  55. 55
    Ekihiro Seki, Bernd Schnabl, Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut, The Journal of Physiology, 2012, 590, 3
  56. 56
    Paul Kubes, Wajahat Z. Mehal, Sterile Inflammation in the Liver, Gastroenterology, 2012, 143, 5, 1158

    CrossRef

  57. 57
    Ivan Levin, Jan Petrasek, Gyongyi Szabo, The Presence of p47phox in Liver Parenchymal Cells is a Key Mediator in the Pathogenesis of Alcoholic Liver Steatosis, Alcoholism: Clinical and Experimental Research, 2012, 36, 8
  58. 58
    Yeon Seok Seo, Vijay H. Shah, The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension, Clinical and Molecular Hepatology, 2012, 18, 4, 337

    CrossRef

  59. 59
    Irina A. Kirpich, Wenke Feng, Yuhua Wang, Yanlong Liu, David F. Barker, Shirish S. Barve, Craig J. McClain, The Type of Dietary Fat Modulates Intestinal Tight Junction Integrity, Gut Permeability, and Hepatic Toll-Like Receptor Expression in a Mouse Model of Alcoholic Liver Disease, Alcoholism: Clinical and Experimental Research, 2012, 36, 5
  60. 60
    Phillipp Hartmann, Michael Haimerl, Magdalena Mazagova, David A. Brenner, Bernd Schnabl, Toll-Like Receptor 2–Mediated Intestinal Injury and Enteric Tumor Necrosis Factor Receptor I Contribute to Liver Fibrosis in Mice, Gastroenterology, 2012, 143, 5, 1330

    CrossRef

  61. 61
    M.W. Lawless, C.M. Greene, Toll-like receptor signalling in liver disease: ER stress the missing link?, Cytokine, 2012, 59, 2, 195

    CrossRef

  62. 62
    Bin Gao, Ramon Bataller, Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets, Gastroenterology, 2011, 141, 5, 1572

    CrossRef

  63. 63
    Timea Csak, Michal Ganz, Justin Pespisa, Karen Kodys, Angela Dolganiuc, Gyongyi Szabo, Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells, Hepatology, 2011, 54, 1
  64. 64
    Bharath Nath, Ivan Levin, Timea Csak, Jan Petrasek, Christian Mueller, Karen Kodys, Donna Catalano, Pranoti Mandrekar, Gyongyi Szabo, Hepatocyte-specific hypoxia-inducible factor-1α is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice, Hepatology, 2011, 53, 5
  65. 65
    María Pascual, Pablo Baliño, Silvia Alfonso-Loeches, Carlos M.G. Aragón, Consuelo Guerri, Impact of TLR4 on behavioral and cognitive dysfunctions associated with alcohol-induced neuroinflammatory damage, Brain, Behavior, and Immunity, 2011, 25, S80

    CrossRef

  66. 66
    Maoyin Pang, Shashi Bala, Karen Kodys, Donna Catalano, Gyongyi Szabo, Inhibition of TLR8- and TLR4-induced Type I IFN induction by alcohol is different from its effects on inflammatory cytokine production in monocytes, BMC Immunology, 2011, 12, 1, 55

    CrossRef

  67. 67
    Jan Petrasek, Angela Dolganiuc, Timea Csak, Bharath Nath, Istvan Hritz, Karen Kodys, Donna Catalano, Evelyn Kurt-Jones, Pranoti Mandrekar, Gyongyi Szabo, Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells , Hepatology, 2011, 53, 2
  68. 68
    Andrew M. Miller, Norio Horiguchi, Won-IL Jeong, Svetlana Radaeva, Bin Gao, Molecular Mechanisms of Alcoholic Liver Disease: Innate Immunity and Cytokines, Alcoholism: Clinical and Experimental Research, 2011, 35, 5
  69. 69
    Jacquelyn J. Maher, New Insights from Rodent Models of Fatty Liver Disease, Antioxidants & Redox Signaling, 2011, 15, 2, 535

    CrossRef

  70. You have free access to this content70
    Jessica I COHEN, Laura E NAGY, Pathogenesis of alcoholic liver disease: interactions between parenchymal and non-parenchymal cells, Journal of Digestive Diseases, 2011, 12, 1
  71. 71
    Herbert Tilg, Alexander R. Moschen, Nicole C. Kaneider, Pathways of liver injury in alcoholic liver disease, Journal of Hepatology, 2011, 55, 5, 1159

    CrossRef

  72. 72
    Jessica I. Cohen, Xiaocong Chen, Laura E. Nagy, Redox Signaling and the Innate Immune System in Alcoholic Liver Disease, Antioxidants & Redox Signaling, 2011, 15, 2, 523

    CrossRef

  73. 73
    María Pascual, Sara Fernández-Lizarbe, Consuelo Guerri, Role of TLR4 in ethanol effects on innate and adaptive immune responses in peritoneal macrophages, Immunology and Cell Biology, 2011, 89, 6, 716

    CrossRef

  74. 74
    Ruth Broering, Mengji Lu, Joerg F. Schlaak, Role of Toll-like receptors in liver health and disease, Clinical Science, 2011, 121, 10, 415

    CrossRef

  75. 75
    Joan Oliva, Fawzia Bardag-Gorce, Jun Li, Barbara A. French, Samuel W. French, S-adenosylmethionine prevents the up regulation of Toll-like receptor (TLR) signaling caused by chronic ethanol feeding in rats, Experimental and Molecular Pathology, 2011, 90, 3, 239

    CrossRef

  76. 76
    G. Szabo, P. Mandrekar, J. Petrasek, D. Catalano, The Unfolding Web of Innate Immune Dysregulation in Alcoholic Liver Injury, Alcoholism: Clinical and Experimental Research, 2011, 35, 5
  77. 77
    Hideto Kawaratani, Tatsuhiro Tsujimoto, Toshiyuki Kitazawa, Hitoshi Yoshiji, Masahito Uemura, Hiroshi Fukui, Therapeutic effects of cytokine modulator Y-40138 in the rat alcoholic liver disease model, Journal of Gastroenterology and Hepatology, 2011, 26, 4
  78. 78
    Sayaka Inokuchi, Hidekazu Tsukamoto, EekJoong Park, Zhang-Xu Liu, David A. Brenner, Ekihiro Seki, Toll-Like Receptor 4 Mediates Alcohol-Induced Steatohepatitis Through Bone Marrow-Derived and Endogenous Liver Cells in Mice, Alcoholism: Clinical and Experimental Research, 2011, 35, 8
  79. 79
    Ekihiro Seki, EekJoong Park, Jiro Fujimoto, Toll-like receptor signaling in liver regeneration, fibrosis and carcinogenesis, Hepatology Research, 2011, 41, 7
  80. 80
    Jan Petrasek, Angela Dolganiuc, Timea Csak, Evelyn A. Kurt–Jones, Gyongyi Szabo, Type I Interferons Protect From Toll-Like Receptor 9–Associated Liver Injury and Regulate IL-1 Receptor Antagonist in Mice, Gastroenterology, 2011, 140, 2, 697

    CrossRef

  81. 81
    Nicholas A. Floreani, Travis J. Rump, P. M. Abdul Muneer, Saleena Alikunju, Brenda M. Morsey, Michael R. Brodie, Yuri Persidsky, James Haorah, Alcohol-Induced Interactive Phosphorylation of Src and Toll-like Receptor Regulates the Secretion of Inflammatory Mediators by Human Astrocytes, Journal of Neuroimmune Pharmacology, 2010, 5, 4, 533

    CrossRef

  82. 82
    Xiongwen Lv, Zhen Chen, Jun Li, Lei Zhang, Hongfeng Liu, Cheng Huang, Pengli Zhu, Caffeine protects against alcoholic liver injury by attenuating inflammatory response and oxidative stress, Inflammation Research, 2010, 59, 8, 635

    CrossRef

  83. 83
    Gyongyi Szabo, Shashi Bala, Jan Petrasek, Arijeet Gattu, Gut-Liver Axis and Sensing Microbes, Digestive Diseases, 2010, 28, 6, 737

    CrossRef

  84. 84
    Bin Gao, Innate Immunity and Steatohepatitis: A Critical Role of Another Toll (TLR-9), Gastroenterology, 2010, 139, 1, 27

    CrossRef

  85. 85
    Sung Hwan Ki, Oygi Park, Mingquan Zheng, Oriol Morales-Ibanez, Jay K. Kolls, Ramon Bataller, Bin Gao, Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: Role of signal transducer and activator of transcription 3, Hepatology, 2010, 52, 4
  86. 86
    Jin-Seok Byun, Won-Il Jeong, Involvement of Hepatic Innate Immunity in Alcoholic Liver Disease, Immune Network, 2010, 10, 6, 181

    CrossRef

  87. 87
    Nympha B. D’Souza El-Guindy, Elizabeth J. Kovacs, Philippe De Witte, Claudia Spies, John M. Littleton, Willem J. S. De Villiers, Amanda J. Lott, Timothy P. Plackett, Nadine Lanzke, Gary G. Meadows, Laboratory Models Available to Study Alcohol-Induced Organ Damage and Immune Variations: Choosing the Appropriate Model, Alcoholism: Clinical and Experimental Research, 2010, 34, 9
  88. 88
    Juliane I. Beier, Craig J. McClain, Mechanisms and cell signaling in alcoholic liver disease, Biological Chemistry, 2010, 391, 11

    CrossRef

  89. 89
    F. Bardag-Gorce, J. Li, J. Oliva, S.C. Lu, B.A. French, S.W. French, The cyclic pattern of blood alcohol levels during continuous ethanol feeding in rats, Experimental and Molecular Pathology, 2010, 88, 3, 380

    CrossRef

  90. 90
    João-Bruno Soares, Pedro Pimentel-Nunes, Roberto Roncon-Albuquerque, Adelino Leite-Moreira, The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases, Hepatology International, 2010, 4, 4, 659

    CrossRef

  91. 91
    Amelie E. Bigorgne, Ian Nicholas Crispe, TLRs in Hepatic Cellular Crosstalk, Gastroenterology Research and Practice, 2010, 2010, 1

    CrossRef

  92. 92
    Jan Petrasek, Pranoti Mandrekar, Gyongyi Szabo, Toll-Like Receptors in the Pathogenesis of Alcoholic Liver Disease, Gastroenterology Research and Practice, 2010, 2010, 1

    CrossRef

  93. 93
    Michael R. Lucey, Philippe Mathurin, Timothy R. Morgan, Alcoholic Hepatitis, New England Journal of Medicine, 2009, 360, 26, 2758

    CrossRef

  94. 94
    Bård Smedsrød, David Le Couteur, Kenichi Ikejima, Hartmut Jaeschke, Norifumi Kawada, Makoto Naito, Percy Knolle, Laura Nagy, Haruki Senoo, Fernando Vidal-Vanaclocha, Noriko Yamaguchi, Hepatic sinusoidal cells in health and disease: update from the 14th International Symposium, Liver International, 2009, 29, 4
  95. 95
    Zhong-bin Deng, Yuelong Liu, Cunren Liu, Xiaoyu Xiang, Jianhua Wang, Ziqiang Cheng, Spandan V. Shah, Shuangyin Zhang, Liming Zhang, Xiaoying Zhuang, Sue Michalek, William E. Grizzle, Huang-Ge Zhang, Immature myeloid cells induced by a high-fat diet contribute to liver inflammation, Hepatology, 2009, 50, 5
  96. 96
    Xiang Li, Mei Yu, Mengjin Zhu, Innate Immune Signaling Pathways in Animals: Beyond Reductionism, International Reviews of Immunology, 2009, 28, 3-4, 207

    CrossRef

  97. 97
    György Baffy, Kupffer cells in non-alcoholic fatty liver disease: The emerging view, Journal of Hepatology, 2009, 51, 1, 212

    CrossRef

  98. 98
    Pranoti Mandrekar, Gyongyi Szabo, Signalling pathways in alcohol-induced liver inflammation, Journal of Hepatology, 2009, 50, 6, 1258

    CrossRef

  99. 99
    Luca Valenti, Anna Ludovica Fracanzani, Silvia Fargion, The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?, Seminars in Immunopathology, 2009, 31, 3, 359

    CrossRef

  100. 100
    Astrid Spruss, Giridhar Kanuri, Sabine Wagnerberger, Synia Haub, Stephan C. Bischoff, Ina Bergheim, Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice, Hepatology, 2009, 50, 4
  101. 101
    Emanuele Albano, New concepts in the pathogenesis of alcoholic liver disease, Expert Review of Gastroenterology & Hepatology, 2008, 2, 6, 749

    CrossRef

  102. 102
    Laura J. Dixon, Mark Barnes, Hui Tang, Michele T. Pritchard, Laura E. Nagy, Kupffer Cells in the Liver, Comprehensive Physiology,
  103. 103
    Patricia Munoz-Garrido, Marco Marzioni, Elizabeth Hijona, Luis Bujanda, Jesus M. Banales, MicroRNAs in Liver Diseases,
  104. 104
    Keigo Machida, Tumor-Initiating Stem-Like Cells,